Telix Pharmaceuticals Limited

ASX:TLX Stock Report

Market Cap: AU$5.5b

Telix Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:TLX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Jul 26BuyAU$26,977,168JPMorgan Chase & Co.Company1,648,940AU$17.61
21 Jul 26SellAU$22,299,252JPMorgan Chase & Co.Company1,390,847AU$17.67
17 Jul 26SellAU$1,107JPMorgan Chase & Co.Company74AU$14.96
13 Jul 26SellAU$28,286JP Morgan Asset ManagementCompany1,769AU$15.99
10 Jul 26BuyAU$27,692JP Morgan Asset ManagementCompany1,702AU$16.27
26 Jun 26BuyAU$18,936,454JPMorgan Chase & Co.Company1,295,296AU$15.97
25 Jun 26SellAU$56,734JP Morgan Asset ManagementCompany3,810AU$15.65
25 Jun 26SellAU$2,936,582JPMorgan Chase & Co.Company188,435AU$15.94
19 Jun 26BuyAU$785,669JP Morgan Asset ManagementCompany54,035AU$14.54
11 Jun 26BuyAU$137,559David GillIndividual10,200AU$13.49
03 Jun 26BuyAU$32,667,053JPMorgan Chase & Co.Company2,256,035AU$15.75
03 Jun 26SellAU$23,740,755JPMorgan Chase & Co.Company1,642,945AU$15.68
01 Jun 26BuyAU$973JPMorgan Chase & Co.Company74AU$13.15
04 May 26SellAU$13,296,503Challenger LimitedCompany856,223AU$15.53
29 Apr 26BuyAU$996,699Christian BehrenbruchIndividual67,935AU$14.67
29 Apr 26BuyAU$1,397,029Christian BehrenbruchIndividual67,935AU$20.84
24 Apr 26BuyAU$4,466,451JPMorgan Chase & Co.Company320,713AU$15.20
24 Apr 26SellAU$1,893,124JPMorgan Chase & Co.Company125,136AU$15.45
15 Apr 26BuyAU$27,058JP Morgan Asset ManagementCompany1,816AU$14.90
14 Apr 26BuyAU$9,529,286JPMorgan Chase & Co.Company1,326,566AU$15.95
14 Apr 26SellAU$13,432,251JPMorgan Chase & Co.Company2,188,808AU$15.77
13 Apr 26SellAU$720,793Challenger LimitedCompany46,000AU$15.67
01 Apr 26SellAU$18,390,973Challenger LimitedCompany1,385,977AU$13.27
30 Mar 26BuyAU$93,835JP Morgan Asset ManagementCompany8,812AU$11.50
25 Mar 26SellAU$28,353JPMorgan Chase & Co.Company2,312AU$13.17
20 Mar 26BuyAU$12,783,232Challenger LimitedCompany1,129,501AU$11.32
19 Mar 26SellAU$1,224,192JP Morgan Asset ManagementCompany100,028AU$12.46
10 Mar 26BuyAU$12,638,819Challenger LimitedCompany1,153,900AU$10.95
05 Mar 26BuyAU$5,915JPMorgan Chase & Co.Company581AU$10.18
05 Mar 26SellAU$1,624,659Challenger LimitedCompany158,600AU$10.24
17 Feb 26BuyAU$7,544,493JPMorgan Chase & Co.Company846,943AU$10.29
17 Feb 26SellAU$2,582,819JPMorgan Chase & Co.Company267,302AU$10.39
04 Feb 26BuyAU$10,096,296JPMorgan Chase & Co.Company904,800AU$11.89
04 Feb 26SellAU$6,652,249JPMorgan Chase & Co.Company591,278AU$11.86
21 Jan 26BuyAU$82,447,874Challenger LimitedCompany5,512,680AU$14.96
21 Jan 26BuyAU$5,880,572JPMorgan Chase & Co.Company544,347AU$11.11
21 Jan 26SellAU$12,154JPMorgan Chase & Co.Company1,138AU$10.68
21 Jan 26SellAU$95,347,977Challenger LimitedCompany7,345,877AU$12.98
20 Jan 26BuyAU$5,404JPMorgan Chase & Co.Company474AU$11.40
20 Jan 26BuyAU$37,502,846JPMorgan Chase & Co.Company2,902,453AU$15.34
20 Jan 26SellAU$362,846JP Morgan Asset ManagementCompany30,266AU$14.27
20 Jan 26SellAU$62,991,087JPMorgan Chase & Co.Company4,967,439AU$15.34
12 Nov 25BuyAU$168,974,482JPMorgan Chase & Co.Company10,122,238AU$25.37
12 Nov 25SellAU$136,400,194JPMorgan Chase & Co.Company8,175,593AU$25.37
10 Nov 25SellAU$3,354,006JP Morgan Asset ManagementCompany237,822AU$23.89
23 Sep 25BuyAU$27,263,052Challenger LimitedCompany1,675,946AU$16.27
23 Sep 25SellAU$1,567,171Challenger LimitedCompany101,000AU$15.52
10 Sep 25SellAU$5,908,796Challenger LimitedCompany425,000AU$13.90
09 Sep 25BuyAU$4,480,509Challenger LimitedCompany318,741AU$14.06
28 Aug 25SellAU$7,173,673Challenger LimitedCompany484,952AU$14.79
22 Aug 25BuyAU$4,553,387Challenger LimitedCompany248,014AU$18.36

Insider Trading Volume

Insider Buying: TLX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TLX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies4,825,9311.42%
Public Companies10,947,1813.22%
Individual Insiders50,399,64614.8%
General Public122,376,85836%
Institutions151,234,67844.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 60.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.95%
JPMorgan Chase & Co.
30,417,227AU$492.5m17.8%0.04%
7.04%
State Street Investment Management
23,930,337AU$387.4m-28.2%0.01%
6.67%
Andreas Kluge
22,675,000AU$367.1m0%no data
6.41%
Christian Behrenbruch
21,796,941AU$352.9m0.31%no data
4.98%
Challenger Limited
16,907,315AU$273.7m-1.14%7.0%
3.35%
Citigroup Inc.
11,391,435AU$184.4m0.53%0.05%
3.22%
Grand Pharmaceutical Group Limited
10,947,181AU$177.2m0%no data
3.11%
Vanguard Capital Management, LLC
10,572,357AU$171.2m12.6%no data
2.26%
Australian Super Pty Ltd
7,687,939AU$124.5m0%0.06%
1.89%
Norges Bank Investment Management
6,429,128AU$104.1m0%no data
1.85%
Vanguard Investments Australia Limited
6,287,673AU$101.8m4.01%0.06%
1.77%
BlackRock, Inc.
6,022,795AU$97.5m-1.55%no data
1.44%
UV-Cap GmbH & Co KG
4,878,261AU$79.0m-10.1%no data
1.28%
RBC Global Asset Management Inc.
4,340,294AU$70.3m-0.44%0.02%
1.07%
Mark Nelson
3,628,750AU$58.7m0%no data
0.74%
Oncidium Foundation
2,513,616AU$40.7m0%no data
0.71%
Netwealth Investments Ltd.
2,406,576AU$39.0m19.7%0.22%
0.58%
BetaShares Capital Limited
1,968,533AU$31.9m4.97%0.07%
0.58%
Sanlam Investments Uk Limited
1,959,548AU$31.7m0%0.72%
0.56%
Lightpoint Medical Ltd
1,918,112AU$31.1m0%no data
0.52%
Yelwac Pty Ltd
1,762,500AU$28.5m0%no data
0.49%
Dimensional Fund Advisors LP
1,680,794AU$27.2m-1.13%no data
0.44%
Portland Investment Counsel Inc.
1,497,964AU$24.3m9.9%4.54%
0.33%
Nancris Pty Ltd
1,136,783AU$18.4m0%no data
0.33%
Harry McCann
1,120,000AU$18.1m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/08 20:19
End of Day Share Price 2026/08/07 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Telix Pharmaceuticals Limited is covered by 23 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Melissa BensonBarrenjoey Markets Pty Limited
John HesterBell Potter
Shane StoreyCanaccord Genuity